Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations ...

The FDA is expected to decide on treatments for COPD, psoriasis, rare neuroendocrine tumors, and a next-generation COVID-19 vaccine.

As scientists, we often think we understand a virus—its structure, its tricks, the way it moves through the body. But every ...

Sniffles? It must be flu.’ We often label minor illnesses as influenza, but the flu is far more dangerous, claiming thousands ...

It's been five years since COVID-19 was declared a global pandemic. As SARS-CoV-2 shifts to endemic status, questions about ...

The COVID-19 pandemic showed in real time, and with the highest of stakes, how hard it can be to decide if something is true.

Broader protection induced by combination of COVID adenovirus vaccine plus CiVax TM compared to 2-shot mRNA vaccination series ...

The publication of Mr. Tufekci’s article in the Times signals a change in the wind of elite opinion. So does the publication ...

Covid-19 is still circulating, though it's weaker now. Experts say it’s not a major threat but advise maintaining strong ...

Perhaps not entirely coincidentally, the Times article appeared one day short of five years from the publication in Nature ...

Perhaps not entirely coincidentally, the Times article appeared one day short of five years from the publication in Nature Medicine of an article by five scientists, led by Kristian Andersen, titled ...

While an estimated 10% to 15% of adults worldwide carry a BAL, the label is often unverified ... with the level still ...